Department of Cardiology, Faculty of Medicine, Atılım University, Medicana International Ankara Hospital, Ankara, Turkey.
Department of Cardiology, Faculty of Medicine, Atılım University, Medicana International Ankara Hospital, Ankara, Turkey.
Ann Thorac Surg. 2021 Dec;112(6):e435-e437. doi: 10.1016/j.athoracsur.2021.03.014. Epub 2021 Mar 16.
The transcatheter tricuspid valve-in-valve implantation has not yet been clarified, and several case series have documented results in patients with tricuspid bioprosthetic valve degeneration who underwent transcatheter implantation of Edwards SAPIEN XT and SAPIEN 3 (Edwards Lifesciences, Irvine, CA) and Medtronic (Minneapolis, MN) valves. Here, we present the case of a patient with severe bioprosthetic tricuspid valve stenosis who was successfully treated with the transfemoral route through the 29-mm novel balloon expandable Myval transcatheter heart valve (Meril Life Sciences Pvt Ltd, Vapi, Gujarat, India) system.
经导管三尖瓣瓣中瓣植入术尚未得到明确,有几项病例系列研究记录了经导管植入爱德华兹 SAPIEN XT 和 SAPIEN 3(爱德华生命科学公司,欧文,加利福尼亚州)和美敦力(明尼阿波利斯,明尼苏达州)瓣膜的三尖瓣生物瓣退行性变患者的结果。在这里,我们介绍了一位严重的生物瓣三尖瓣狭窄患者的病例,该患者通过经股动脉途径成功地使用了 29 毫米新型球囊扩张的 Myval 经导管心脏瓣膜(Meril Life Sciences Pvt Ltd,瓦皮,古吉拉特邦,印度)系统进行了治疗。